According to The National Law Review, a revised outbound investment rule extends its coverage to biotech and super intelligence. The outlet describes the change as an extension, which means the rule now reaches areas beyond its earlier scope.
The headline does not give further details. This brief therefore does not describe the exact scope of the rule, the agency behind it or any dates.
